Development and evaluation of deuterated [18F]JHU94620 isotopologues for the non-invasive assessment of the cannabinoid type 2 receptor in brain

IF 4.4 Q1 CHEMISTRY, INORGANIC & NUCLEAR EJNMMI Radiopharmacy and Chemistry Pub Date : 2024-12-23 DOI:10.1186/s41181-024-00319-2

Daniel Gündel, Mudasir Maqbool, Rodrigo Teodoro, Friedrich-Alexander Ludwig, Anne Heerklotz, Magali Toussaint, Winnie Deuther-Conrad, Guy Bormans, Peter Brust, Klaus Kopka, Rareş-Petru Moldovan

{"title":"Development and evaluation of deuterated [18F]JHU94620 isotopologues for the non-invasive assessment of the cannabinoid type 2 receptor in brain","authors":"Daniel Gündel, Mudasir Maqbool, Rodrigo Teodoro, Friedrich-Alexander Ludwig, Anne Heerklotz, Magali Toussaint, Winnie Deuther-Conrad, Guy Bormans, Peter Brust, Klaus Kopka, Rareş-Petru Moldovan","doi":"10.1186/s41181-024-00319-2","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>The cannabinoid type 2 receptors (CB2R) represent a target of increasing importance in neuroimaging due to its upregulation under various neuropathological conditions. Previous evaluation of [<sup>18</sup>F]JHU94620 for the non-invasive assessment of the CB2R availability by positron emission tomography (PET) revealed favourable binding properties and brain uptake, however rapid metabolism, and generation of brain-penetrating radiometabolites have been its main limitations. To reduce the bias of CB2R quantification by blood–brain barrier (BBB)-penetrating radiometabolites, we aimed to improve the metabolic stability by developing -<i>d</i><sub>4</sub> and -<i>d</i><sub>8</sub> deuterated isotopologues of [<sup>18</sup>F]JHU94620.</p><h3>Results</h3><p>The deuterated [<sup>18</sup>F]JHU94620 isotopologues showed improved metabolic stability avoiding the accumulation of BBB-penetrating radiometabolites in the brain over time. CB2R-specific binding with <i>K</i><sub>D</sub> values in the low nanomolar range was determined across species. Dynamic PET studies revealed a CB2R-specific and reversible uptake of [<sup>18</sup>F]JHU94620-<i>d</i><sub>8</sub> in the spleen and to a local <i>h</i>CB2R(D80N) protein overexpression in the striatal region in rats.</p><h3>Conclusion</h3><p>These results support further investigations of [<sup>18</sup>F]JHU94620-<i>d</i><sub>8</sub> in pathological models and tissues with a CB2R overexpression as a prerequisite for clinical translation.</p></div>","PeriodicalId":534,"journal":{"name":"EJNMMI Radiopharmacy and Chemistry","volume":"9 1","pages":""},"PeriodicalIF":4.4000,"publicationDate":"2024-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ejnmmipharmchem.springeropen.com/counter/pdf/10.1186/s41181-024-00319-2","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EJNMMI Radiopharmacy and Chemistry","FirstCategoryId":"1085","ListUrlMain":"https://link.springer.com/article/10.1186/s41181-024-00319-2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, INORGANIC & NUCLEAR","Score":null,"Total":0}

引用次数: 0

Abstract

Background

The cannabinoid type 2 receptors (CB2R) represent a target of increasing importance in neuroimaging due to its upregulation under various neuropathological conditions. Previous evaluation of [¹⁸F]JHU94620 for the non-invasive assessment of the CB2R availability by positron emission tomography (PET) revealed favourable binding properties and brain uptake, however rapid metabolism, and generation of brain-penetrating radiometabolites have been its main limitations. To reduce the bias of CB2R quantification by blood–brain barrier (BBB)-penetrating radiometabolites, we aimed to improve the metabolic stability by developing -d₄ and -d₈ deuterated isotopologues of [¹⁸F]JHU94620.

Results

The deuterated [¹⁸F]JHU94620 isotopologues showed improved metabolic stability avoiding the accumulation of BBB-penetrating radiometabolites in the brain over time. CB2R-specific binding with K_D values in the low nanomolar range was determined across species. Dynamic PET studies revealed a CB2R-specific and reversible uptake of [¹⁸F]JHU94620-d₈ in the spleen and to a local hCB2R(D80N) protein overexpression in the striatal region in rats.

Conclusion

These results support further investigations of [¹⁸F]JHU94620-d₈ in pathological models and tissues with a CB2R overexpression as a prerequisite for clinical translation.

查看原文